Key Elements Affecting Biosimilar Uptake in the United States

Article
Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
Related Content
Image credit: Iliya Mitskavets | stock.adobe.com

Considerations When Treating Migraines in Gender Diverse Patients Receiving Gender-Affirming Hormone Therapy

April 23rd 2024
Article
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

January 25th 2024
Podcast
Microglia are immune cells in the brain | Image Credit: Artur - stock.adobe.com

Study: Frexalimab Shows Sustained Reduction of Disease Activity for Multiple Sclerosis

April 23rd 2024
Article
Pharmacy Focus: Policy Edition - PBM Audits

Pharmacy Focus: Policy Edition - PBM Audits

January 24th 2024
Podcast
3d rendered illustration of lung cancer 3D illustration | Image Credit: appledesign - stock.adobe.com

Samsung Bioepis Initiates Phase 3 Clinical Trial for Proposed Pembrolizumab Biosimilar

April 22nd 2024
Article
nerve cells, Neurologic Disease, tumors, brain surgery | Image Credit: ralwel - stock.adobe.com

Ocrelizumab Demonstrates Near-Complete Suppression of Relapses for Multiple Sclerosis

April 22nd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.